TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
51.40
+0.40 (0.78%)
Mar 10, 2026, 9:45 AM CST

TSH Biopharm Corporation Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
464.54588.34576.59488.9381.89
Upgrade
Short-Term Investments
30.74309.02195.54326.86351.52
Upgrade
Cash & Short-Term Investments
495.28897.36772.12815.77733.41
Upgrade
Cash Growth
-44.81%16.22%-5.35%11.23%1.07%
Upgrade
Accounts Receivable
312.34211.68208.33202.5599.07
Upgrade
Other Receivables
2.352.392.181.831.06
Upgrade
Receivables
314.69214.07210.51204.38100.13
Upgrade
Inventory
155.74176.08118.4107.3973.22
Upgrade
Prepaid Expenses
18.5416.799.29--
Upgrade
Other Current Assets
438.770.413.4415.3713.22
Upgrade
Total Current Assets
1,4231,3051,1141,143919.97
Upgrade
Property, Plant & Equipment
35.6440.4132.6841.6427.36
Upgrade
Long-Term Investments
179.15192.63188.89179.08212.06
Upgrade
Goodwill
-247.9---
Upgrade
Other Intangible Assets
289.4839.7553.6464.073.63
Upgrade
Long-Term Deferred Tax Assets
2.674.011.511.82.01
Upgrade
Other Long-Term Assets
21.512.789.395.624.39
Upgrade
Total Assets
1,9511,8421,4001,4351,169
Upgrade
Accounts Payable
48.6371.3651.4257.6412.72
Upgrade
Accrued Expenses
-56.6935.2137.444.77
Upgrade
Short-Term Debt
---20-
Upgrade
Current Portion of Long-Term Debt
---18.85-
Upgrade
Current Portion of Leases
11.9510.17.47.324.57
Upgrade
Current Income Taxes Payable
26.6832.232.978.027.1
Upgrade
Current Unearned Revenue
3.241.041.845.43-
Upgrade
Other Current Liabilities
136.637.4834.7950.8516.64
Upgrade
Total Current Liabilities
227.09208.9133.63205.585.8
Upgrade
Long-Term Debt
---9.6-
Upgrade
Long-Term Leases
6.710.33-7.36-
Upgrade
Total Liabilities
233.79219.23133.63222.4685.8
Upgrade
Common Stock
383.98383.98383.98383.98383.98
Upgrade
Additional Paid-In Capital
459.61459.55459.5459.44459.36
Upgrade
Retained Earnings
581.2480.68204.14228.37224.08
Upgrade
Comprehensive Income & Other
17.8267.5859.9822.5816.21
Upgrade
Total Common Equity
1,4431,3921,1081,0941,084
Upgrade
Minority Interest
275.06231.18158.63118.31-
Upgrade
Shareholders' Equity
1,7181,6231,2661,2131,084
Upgrade
Total Liabilities & Equity
1,9511,8421,4001,4351,169
Upgrade
Total Debt
18.6420.437.463.134.57
Upgrade
Net Cash (Debt)
476.64876.93764.73752.64728.84
Upgrade
Net Cash Growth
-45.65%14.67%1.60%3.27%1.67%
Upgrade
Net Cash Per Share
12.3922.8119.9019.5718.96
Upgrade
Filing Date Shares Outstanding
38.2638.438.438.438.4
Upgrade
Total Common Shares Outstanding
38.2638.438.438.438.4
Upgrade
Working Capital
1,1961,096980.13937.41834.17
Upgrade
Book Value Per Share
37.7036.2528.8528.5028.22
Upgrade
Tangible Book Value
1,1531,1041,0541,0301,080
Upgrade
Tangible Book Value Per Share
30.1428.7627.4526.8328.13
Upgrade
Land
-5.855.855.855.85
Upgrade
Buildings
-14.214.213.9413.94
Upgrade
Machinery
-47.6833.1331.4122.48
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.